Who owns ACRIVON THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Acrivon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acrivon Therapeutics stock

Who bought or sold ACRIVON THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
RA Capital Management 8.3M $12M 0% Mar 2026
 View chart
Sands Capital Ventures 2.1M $3.0M 0% Mar 2026
 View chart
Wellington Management Company 888k $2.1M 0% Dec 2025
 View chart
Acadian Asset Management 846k $1.2M 46% Mar 2026
 View chart
Vanguard Capital Management 722k $1.0M 100% Mar 2026
 View chart
Vanguard Group 699k $1.7M 12% Dec 2025
 View chart
Renaissance Technologies 634k $1.5M 2% Dec 2025
 View chart
Marshall Wace 496k $1.2M 231% Dec 2025
 View chart
Acorn Capital Advisors 405k $977k 0% Dec 2025
 View chart
Two Sigma Investments 389k $541k -33% Mar 2026
 View chart
Jane Street 240k $333k -30% Mar 2026
 View chart
Geode Capital Management 236k $329k 19% Mar 2026
 View chart
BlackRock 209k $290k 2% Mar 2026
 View chart
GSA Capital Partners 187k $260k 100% Mar 2026
 View chart
Vanguard Fiduciary Trust 108k $150k 100% Mar 2026
 View chart
State Street Corporation 67k $162k 0% Dec 2025
 View chart
Northern Trust 64k $154k 51% Dec 2025
 View chart
Springbok Capital Management 48k $116k 100% Dec 2025
 View chart
Bridgeway Capital Management 43k $103k 87% Dec 2025
 View chart
Morgan Stanley 37k $51k -22% Mar 2026
 View chart
UBS Group 35k $48k -90% Mar 2026
 View chart
PanAgora Asset Management 34k $47k 100% Mar 2026
 View chart
Squarepoint Ops 28k $38k 5% Mar 2026
 View chart
Barclays 24k $59k 22% Dec 2025
 View chart
Quadrature Capital 21k $50k 100% Dec 2025
 View chart
XTX Topco 21k $50k -43% Dec 2025
 View chart
Marex Group 20k $28k 100% Mar 2026
 View chart
Dimensional Fund Advisors 18k $26k 0% Mar 2026
 View chart
Bank of America Corporation 17k $23k 100% Mar 2026
 View chart
Goldman Sachs Group 15k $21k -88% Mar 2026
 View chart
Susquehanna International 12k $30k 100% Dec 2025
 View chart
Two Sigma Securities 12k $16k 100% Mar 2026
 View chart
AAFCPAs Wealth Management 11k $15k 0% Mar 2026
 View chart
FMR 8.6k $21k 0% Dec 2025
 View chart
Federated Investors 7.9k $11k 41% Mar 2026
 View chart
Vanguard Global Advisers 4.5k $6.2k 100% Mar 2026
 View chart
Wells Fargo & Company 3.0k $4.2k 100% Mar 2026
 View chart
Bnp Paribas Arbitrage, Snc 634.00 $881.006400 0% Mar 2026
 View chart
NISA Investment Advisors 584.00 $811.993600 0% Mar 2026
 View chart
Redwood Park Advisors 500.00 $695.000000 0% Mar 2026
 View chart
Russell Investments 481.00 $669.022900 0% Mar 2026
 View chart
Federation des caisses Desjardins du Quebec 400.00 $556.000000 0% Mar 2026
 View chart
Steward Partners Investment Advisory 326.00 $453.009600 100% Mar 2026
 View chart
SBI Securities 74.00 $103.000600 0% Mar 2026
 View chart
Royal Bank of Canada 25.00 $0 -97% Mar 2026
 View chart
Caitong International Asset Management 4.00 $6.000000 100% Mar 2026
 View chart

Who sold out of Acrivon Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Dec 2025 1.6M $4.0M
Two Sigma Advisers Dec 2025 334k $804k
Millennium Management Dec 2025 122k $293k
Bluefin Capital Management Sep 2025 42k $76k
Baker Bros. Advisors Dec 2025 23k $55k
Colony Sep 2025 20k $988k
Vermillion & White Wealth Management Group Dec 2025 18k $44k
Schonfeld Strategic Advisors Dec 2025 16k $40k
Point72 Asset Management Dec 2025 11k $26k
Tower Research Capital Sep 2025 8.7k $16k
Jpmorgan Chase & Co Sep 2025 1.7k $3.2k
EverSource Wealth Advisors Dec 2025 373.00 $899.004600
Optima Capital Dec 2025 278.00 $670.007800
CWM Sep 2025 127.00 $0